|
1
|
Hajjar S, Memish ZA and McIntosh K: Middle
east respiratory syndrome coronavirus (MERS-CoV): A perpetual
challenge. Ann Saudi Med. 33:427–436. 2013.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Pustake M, Tambolkar I, Giri P and Gandhi
C: SARS, MERS and CoVID-19: An overview and comparison of clinical,
laboratory and radiological features. J Family Med Prim Care.
11:10–17. 2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Cucinotta D and Vanelli M: WHO declares
COVID-19 pandemic. Acta Biomed. 91:157–160. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Pujari R, Thommana MV, Mercedes BR and
Serwat A: Therapeutic options for COVID-19: A review. Cureus.
12(e10480)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Vegivinti CTR, Evanson KW, Lyons H,
Akosman I, Barrett A, Hardy N, Kane B, Keesari PR, Pulakurthi YS,
Sheffels E, et al: Efficacy of antiviral therapies for COVID-19: A
systematic review of randomized controlled trials. BMC Infect Dis.
22(107)2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Iacob S and Iacob DG: SARS-CoV-2 treatment
approaches: Numerous options, no certainty for a versatile virus.
Front Pharmacol. 11(1224)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zadeh NM, Asl NSM, Forouharnejad K,
Ghadimi K, Parsa S, Mohammadi S and Omidi A: Mechanism and adverse
effects of COVID-19 drugs: A basic review. Int J Physiol Pathopsyol
Pharmacol. 13:102–109. 2021.PubMed/NCBI
|
|
8
|
da Rosa Mesquita R, Junior LC, Santana FM,
de Oliveira TF, Alcântara RC, Arnozo GM, da Silva Filho ER, Dos
Santos AGG, da Cunha EJO, de Aquino SHS and de Souza CDF: Clinical
manifestations of COVID-19 in the general population: Systematic
review. Wien Klin Wochenschr. 133:377–382. 2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhang JJ, Dong X, Liu GH and Gao YD: Risk
and protective factors for COVID-19 morbidity, severity, and
mortality. Clin Rev Allergy Immunol. 64:90–107. 2023.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kukar M, Gunčar G, Vovko T, Podnar S,
Černelč P, Brvar M, Zalaznik M and Notar M, Moškon S and Notar M:
COVID-19 diagnosis by routine blood tests using machine learning.
Sci Rep. 11(10738)2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Castro AA, Antonio TD, Martínez EC,
Gallardo MM, Gascón ML and Pinos DD: Usefulness of chest X-rays for
evaluating prognosis in patients with COVID-19. Radiologia (Engl
Ed). 63:476–483. 2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hesam-Shariati S, Mohammadi S,
Abouzaripour M, Mohsenpour B, Zareie B, Sheikholeslomzadeh H,
Rajabi F and Shariat MBH: Clinical and CT scan findings in patients
with COVID-19 pneumonia: A comparison based on disease severity.
Egypt J Bronchol. 16(39)2022.
|
|
13
|
Sekihara K, Shibasaki T, Okamoto T,
Matsumoto C, Ito K, Fujimoto K, Kato F, Matsuda W, Kobayashi K,
Sasaki R, et al: Poor prognosis of patients with severe COVID-19
admitted to an infectious disease intensive care unit during the
pandemic caused by the Delta variant in Japan. Glob Health Med.
4:122–128. 2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
COVID-19 Treatment Guidelines Panel.
Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National
Institutes of Health. Available at https://www.covid19treatmentguidelines.nih.gov/.
Accessed April 1 2023. Clinical Spectrum of SARS-CoV-2. Infection.
Last updated March 6, 2023.
|
|
15
|
Armstrong RA, Kane AD, Kursumovic E,
Oglesby FC and Cook TM: Mortality in patients admitted to intensive
care with COVID-19: An updated systematic review and meta-analysis
of observational studies. Anaesthesia. 76:537–548. 2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Li Y, Ashcroft T, Chung A, Dighero I,
Dozier M, Horne M, McSwiggan E, Shamsuddin A and Nair H: Risk
factors for poor outcomes in hospitalised COVID-19 patients: A
systematic review and meta-analysis. J Glob Health.
11(10001)2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Khedr EM, Daef E, Mohamed-Hussein A,
Mostafa EF, Zein M, Hassany SM, Galal H, Hassan SA, Galal I,
Zarzour AA, et al: Comorbidities and putcomes among patients
hospitalized with COVID-19 in upper Egypt. Egypt J Neurol Psyciatr
Neurosurg. 58(92)2022.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Dessie ZG and Zewotir T: Mortality-related
risk factors of COVID-19: A systematic review and meta-analysis of
42 studies and 423,117 patients. BMC Infect Dis.
21(855)2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhang JJ, Dong X, Liu GH and Gao YD: Risk
and protective factors for COVID-19 morbidity, severity, and
mortality. Clin Rev Allerg Immunol. 64:90–107. 2023.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Ashton RE, Philips BE and Faghy M: The
acute and chronic implications of the COVID-19 virus on the
cardiovascular system in adults: A systematic review. Prog
Cardiovasc Dis. 76:31–37. 2023.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Italia L, Tomasoni D, Bisegna S, Pancaldi
E, Stretti L, Adamo M and Metra M: COVID-19 and heart failure: From
epidemiology during the pandemic to myocardial injury, myocarditis,
and heart failure sequelae. Front Cardiovasc Med.
8(713560)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Corona G, Pizzocaro A, Vena W, Rastrelli
G, Semeraro F, Isidori AM, Pivonello R, Salonia A, Sforza A and
Maggi M: Diabetes is most important cause for mortality in COVID-19
hospitalized patients: Systematic review and meta-analysis. Rev
Endocr Metab Disord. 22:275–296. 2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Sharma P, Behl T, Sharma N, Singh S,
Grewal AS, Albarrati A, Albratty M, Meraya AM and Bungau S:
COVID-19 and diabetes: Association intensify risk factors for
morbidity and mortality. Biomed Pharmacother.
151(113089)2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Jdiaa SS, Mansour R, El Alayli A, Gautam
A, Thomas P and Mustafa RA: COVID-19 and chronic kidney disease: An
updated overview of reviews. J Nephrol. 35:69–85. 2022.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Lazcano U, Cuadrado-Godia E, Grau M,
Subirana I, Martínez-Carbonell E, Boher-Massaguer M,
Rodríguez-Campello A, Giralt-Steinhauer E, Fernández-Pérez I,
Jiménez-Conde J, et al: Increased COVID-19 mortality in people with
previous cerebrovascular disease: A population-based cohort study.
Stroke. 53:1276–1284. 2022.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Turnquist C, Ryan BM, Horikawa I, Harris
BT and Harris CC: Cytokine storms in cancer and COVID-19. Cancer
Cell. 38:598–601. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Li Y, Deng Y, Ye L, Sun H, Du S, Huang H,
Zeng F, Chen X and Deng G: Clinical significance of plasma d-dimer
in COVID-19 mortality. Front Med (Lausanne).
8(638097)2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yao Y, Cao J, Wang Q, Shi Q, Liu K, Luo Z,
Chen X, Chen S, Yu K, Huang Z and Hu B: D-dimer as a biomarker for
disease severity and mortality in COVID-19 patients: A case control
study. J Intensive care. 8(49)2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Buonacera A, Stancanelli B, Colaci M and
Malatino L: Neutrophil to lymphocyte ratio: An emerging marker of
the relationships between the immune system and diseases. Int J Mol
Sci. 23(3636)2022.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Forget P, Khalifa C, Defour JP, Latinne D,
Van Pel MC and De Kock M: What is the normal value of the
neutrophil-to-lymphocyte ratio? BMC Res Notes.
10(12)2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Toori KU, Qureshi MA, Chaudhry A and
Safdar MF: Neutrophil to lymphocyte ratio (NLR) in COVID-19: A
cheap prognostic marker in a resource constraint setting. Pak J Med
Sci. 37:1435–1439. 2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Mejía F, Medina C, Cornejo E, Morello E,
Vásquez S, Alave J, Schwalb A and Málaga G: Oxygen saturation as a
predictor of mortality in hospitalized adult patients with COVID-19
in a public hospital in Lima, Peru. PLoS One.
15(e0244171)2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng
J, Li Q, Jiang C, Zhou Y, Liu S, et al: Risk factors of critical
& mortal COVID-19 cases: A systematic literature review and
meta-analysis. J Infect. 81:e16–e25. 2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Shi L, Wang Y, Wang Y, Duan G and Yang H:
Dyspnea rather than fever is a risk factor for predicting mortality
in patients with COVID-19. J Infect. 81:647–679. 2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Cann SAH: Fever: Could a cardinal sign of
COVID-19 infection reduce mortality? Am J Med Sci. 361:420–426.
2021.PubMed/NCBI View Article : Google Scholar
|
